{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:56:43Z","timestamp":1789376203227,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00325","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T10:57:54Z","timestamp":1474369074000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Linezolid Toxicity and Mitochondrial Susceptibility: A Novel Neurological Complication in a Lebanese Patient"],"prefix":"10.3389","volume":"7","author":[{"given":"Ossama K.","family":"Abou Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Karnib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyad","family":"El-Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouha","family":"Ahdab-Barmada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"BouKhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM200301023480123","article-title":"Linezolid-induced lactic acidosis.","volume":"348","author":"Apodaca","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.freeradbiomed.2012.02.038","article-title":"Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis.","volume":"52","author":"Arimura","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1592\/phco.27.5.771","article-title":"Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.","volume":"27","author":"Carson","year":"2007","journal-title":"Pharmacotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis.","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"e1003182","key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003182","article-title":"Alternative oxidase expression in the mouse enables bypassing cytochrome c oxidase blockade and limits mitochondrial ROS overproduction.","volume":"9","author":"El-Khoury","year":"2013","journal-title":"PLoS Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s15010-005-4057-9","article-title":"Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.","volume":"33","author":"Ferry","year":"2005","journal-title":"Infection"},{"key":"B7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00415-009-5340-y","article-title":"Early onset probable linezolid-induced encephalopathy.","volume":"257","author":"Fletcher","year":"2010","journal-title":"J. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1128\/AAC.01190-06","article-title":"Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.","volume":"51","author":"Garrabou","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/postgradmedj-2011-130326","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people.","volume":"88","author":"Goodfellow","year":"2012","journal-title":"Postgrad. Med. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2014.12.009","article-title":"Incidence and risk factors of linezolid-induced lactic acidosis.","volume":"31","author":"Im","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2007.04.005","article-title":"The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.","volume":"26","author":"Leach","year":"2007","journal-title":"Mol. Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00439-014-1421-9","article-title":"Characterization of mitochondrial haplogroups in a large population-based sample from the United States.","volume":"133","author":"Mitchell","year":"2014","journal-title":"Hum. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40121-014-0032-z","article-title":"A retrospective review of the clinical experience of linezolid with or without rifampicin in prosthetic joint infections treated with debridement and implant retention.","volume":"3","author":"Morata","year":"2014","journal-title":"Infect. Dis. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archneur.64.5.746","article-title":"Linezolid-induced posterior reversible leukoencephalopathy syndrome.","volume":"64","author":"Nagel","year":"2007","journal-title":"Arch. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1128\/AAC.49.9.3896","article-title":"Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis.","volume":"49","author":"Nagiec","year":"2005","journal-title":"Society"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/hmg\/dds517","article-title":"Mitochondrial antibiograms in personalized medicine.","volume":"22","author":"Pacheu-Grau","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1086\/430441","article-title":"Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?","volume":"40","author":"Palenzuela","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ebiom.2015.09.051","article-title":"Linezolid trough concentrations correlate with mitochondrial toxicity-related adverse events in the treatment of chronic extensively drug-resistant tuberculosis.","volume":"2","author":"Song","year":"2015","journal-title":"EBioMedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJM200511243532123","article-title":"Mitochondrial toxicity associated with linezolid.","volume":"353","author":"Soriano","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13339","DOI":"10.1073\/pnas.0804276105","article-title":"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning.","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T13:09:09Z","timestamp":1475586549000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00325\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":21,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00325","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}